Optimizing Oracle Health (Cerner) Prior Authorization for Genetic Testing

Klivira automates the complex and often manual process of Oracle Health (Cerner) prior authorization for genetic testing, directly integrating with clinician workflows to reduce administrative burden and accelerate patient access to care.

Genetic testing, encompassing critical services like hereditary cancer panels, prenatal diagnostics, and pharmacogenomics, frequently triggers prior authorization requirements. For health systems leveraging Oracle Health (Cerner), managing these PAs within PowerChart can lead to significant context switching and operational inefficiencies. Klivira addresses these challenges head-on, delivering a streamlined solution.

The Challenge of Genetic Testing PAs within Oracle Health (Cerner)

Genetic testing orders, often initiated within Cerner's Orders activity, require meticulous prior authorization. This process frequently involves navigating external RBMs such as eviCore and Avalon Healthcare Services, leading to PowerChart context switching and heavy reliance on fax-based workflows or manual payer portal fatigue. The complexity of clinical documentation for high-volume categories like hereditary cancer panels further exacerbates these pain points.

Klivira's Integrated Solution for Oracle Health (Cerner) and Genetic Testing

Klivira integrates directly with Oracle Health (Cerner) via SMART on FHIR, providing a seamless experience for prior authorization coordinators and clinicians. Our platform launches directly from PowerChart, detecting genetic testing orders and automating the data extraction necessary for PA submission, minimizing manual data entry and reducing errors. This keeps the PA process within the EMR context, reducing the need for separate portal logins.

Key Integration Points for Genetic Testing PA Automation

**SMART on FHIR Launch**: Klivira launches from within PowerChart, providing patient and encounter context for genetic testing orders (src: smart-app-launch).
**CDS Hooks for PA Detection**: Leveraging CDS Hooks at order entry (e.g., `order-select`), Klivira identifies genetic testing orders requiring prior authorization, such as hereditary cancer panels (src: cds-hooks).
**FHIR R4 Data Exchange**: Securely extracts relevant clinical data (e.g., Patient, Condition, Observation, ServiceRequest) via FHIR R4 APIs to build comprehensive PA packets (src: cerner-fhir, us-core).
**HL7 v2 Interoperability**: Augments FHIR workflows by processing admission and order events via existing HL7 v2 interfaces in production Cerner deployments.
**Automated RBM Interaction**: Submits PA requests to common RBMs like eviCore and Avalon Healthcare Services, and payer portals, automating status checks and documentation submission.

Streamlining High-Volume Genetic Testing Categories

Klivira is purpose-built to handle the specific requirements of high-volume genetic testing categories. For hereditary cancer panels, prenatal genetic testing, and pharmacogenomics, our platform ensures that the necessary clinical documentation is accurately compiled and submitted, aligning with payer and RBM guidelines. This includes leveraging Cerner's Documents / Clinical Notes for supporting information and facilitating write-back of PA status to the Message Center or DocumentReference where supported by customer configuration.

Enhancing Operational Efficiency and Compliance

By automating the Oracle Health (Cerner) prior authorization for genetic testing, Klivira helps health systems reduce manual effort, accelerate turnaround times, and improve denial rates. Our platform is designed to support efficient workflows for prior authorization coordinators, allowing them to focus on high-value tasks and patient care, while ensuring documentation integrity within the EMR. Clients should consult their compliance teams to ensure all automated workflows align with organizational policies.

Frequently asked questions

How does Klivira integrate with Oracle Health (Cerner) for genetic testing prior authorizations?

Klivira integrates using SMART on FHIR to launch directly from PowerChart, leveraging CDS Hooks to detect genetic testing orders. It uses FHIR R4 and HL7 v2 interfaces to extract patient data, then automates submission to payers and RBMs like eviCore and Avalon Healthcare Services. Status updates can be written back to Cerner's Message Center or Documents.

Can Klivira handle specific genetic testing categories like hereditary cancer panels?

Yes, Klivira is designed to manage prior authorizations for high-volume genetic testing categories, including hereditary cancer panels, prenatal genetic testing, and pharmacogenomics. Our system ensures the specific documentation requirements for these complex tests are met and submitted to the relevant payers or RBMs.

What Cerner modules does Klivira interact with during the PA process?

Klivira primarily interacts with PowerChart, specifically launching from the Orders activity. It pulls clinical data from patient charts and documentation within Cerner and can push PA status updates to the Message Center or write documentation back to Clinical Notes/DocumentReference, depending on customer configuration.

Does Klivira reduce context switching for prior authorization coordinators using Cerner?

Absolutely. By integrating directly into PowerChart via SMART on FHIR, Klivira minimizes the need for coordinators to leave the Cerner environment. This significantly reduces context switching and eliminates the need to manually log into multiple payer portals or manage fax-based workflows for genetic testing PAs.

How does Klivira handle RBMs like eviCore and Avalon Healthcare Services for genetic testing?

Klivira automates the interaction with RBMs such as eviCore and Avalon Healthcare Services. Our platform is configured to submit the necessary clinical information and documentation directly to these entities, track the PA status, and relay updates back to the Oracle Health (Cerner) system, streamlining a common source of PA complexity.